- $91.53m
- $99.68m
- $135.00m
Brief: Dermot Smurfit Resigns As Gan Ltd's Chief Executive Officer And Director Of Company And Operating Units
Brief: Gan Ltd Says Q1 Net Income Of $1.5 Mln
Brief: Gan Reports First Quarter 2023 Financial Results
Gan Ltd expected to post a loss of 18 cents a share - Earnings Preview
Gan Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Gan Ltd Reports Quarterly Loss Per Share Of $3.46
Gan Ltd expected to post a loss of 12 cents a share - Earnings Preview
Effective December 21, 2022, Gan Limited’S President, Enterprise Solutions, Don Ryan, Is No Longer With The Company
Brief: Gan Announces Departure Of Chief Financial Officer
Brief: Gan Ltd Reports Quarterly Results
Brief: GAN Reports Third Quarter 2022 Financial Results
Brief: Gan Announces Appointment Of Mr. Eric J. Green To Its Board Of Directors
GAN tumbles after Q2 loss widens, rev misses estimate
Brief: GAN Reports Q2 2022 Financial Results
Brief: Gan Repurchases $1 Million Of Common Shares Under Share Repurchase Authorization In Second Quarter
Brief: Gan Announces Extension Of Share Repurchase Plan
Brief: Gan Provides Strategic Update And Announces Successful Completion Of $30 Million Term Loan
U.S. RESEARCH ROUNDUP- Codexis, Ionis Pharmaceuticals, Travere Therapeutics
Gan Ltd's Nasdaq-listed shares plummet after downbeat forecast for 2022